Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021

  • ID: 4144144
  • Report
  • 135 Pages
  • Markets and Markets
1 of 5
Anatomic Pathology Market worth 21.9 Billion USD by 2021

FEATURED COMPANIES

  • Bio SB
  • Biogenex Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG.
  • MORE

The anatomic pathology market was valued at USD 16.2 billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 billion in 2021. Anatomic pathology is used for the diagnosis of various types of chronic diseases such as cancer and infectious diseases. Moreover, it is used in the pharmaceutical industries to conduct toxicology studies. The anatomic pathology market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

Based on product & service, the anatomic pathology market is segmented into instruments, consumables, and services. The instruments segment has been subsegmented into tissue processing systems, slides staining systems, microtomes, and other instruments. Similarly, the consumables segment has been subsegmented into reagents & antibodies, probes, kits, and other consumables. Likewise, the services segment has been subsegmented into cytopathology, histopathology, and other services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

Based on application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. In 2016, the disease diagnosis segment accounted for the largest share of the market. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.

Geographically, the anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this market.

In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the anatomic pathology market.

Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the anatomic pathology market. The report analyzes the anatomic pathology market by product & service and application
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the anatomic pathology market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the anatomic pathology market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various anatomic pathology products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the anatomic pathology market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bio SB
  • Biogenex Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data from Secondary Sources
2.2 Primary Data
2.2.1 Key Data from Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction

4 Premium Insights
4.1 Anatomic Pathology Market: Market Overview
4.2 Geographic Analysis: Anatomic Pathology Market, By Product & Service
4.3 Anatomic Pathology Market Size, By Application, 2016 vs. 2021
4.4 Anatomic Pathology Market Size, By Region, 2016-2021

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Cancer
5.2.1.2 Rapid Growth in the Geriatric Population
5.2.1.3 Growing Healthcare Expenditure
5.2.2 Restraints
5.2.2.1 Imposition of Excise Duty By the U.S. Government
5.2.2.2 Stringent Regulations and Changing Requirements
5.2.3 Opportunities
5.2.3.1 Rapid Growth in the Emerging Markets of Apac and Latin America
5.2.3.2 Increased Demand for Personalized Medicine
5.2.4 Challenges
5.2.4.1 High Degree of Consolidation
5.2.5 Trends
5.2.5.1 Increasing Number of Reagent Rental Agreements

6 Anatomic Pathology Market, By Product & Service
6.1 Introduction
6.2 Instruments
6.2.1 Tissue Processing Systems
6.2.2 Slide Staining Systems
6.2.3 Microtomes
6.2.4 Other Instruments
6.3 Consumables
6.3.1 Antibodies & Reagents
6.3.2 Kits
6.3.3 Probes
6.3.4 Other Consumables
6.4 Services
6.4.1 Cytopathology
6.4.2 Histopathology
6.4.3 Other Services

7 Anatomic Pathology Market, By Application
7.1 Introduction
7.2 Diseases Diagnosis
7.3 Drug Discovery & Development
7.4 Other Applications

8 Anatomic Pathology Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.1.1 Strategic Overview
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Product Launches & Regulatory Approvals
9.3.2 Acquisitions
9.3.3 Agreements, Partnerships, and Collaborations
9.3.4 Expansions

10 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development) -
10.1 Introduction
10.2 F. Hoffmann-La Roche AG.
10.3 Danaher Corporation
10.4 Thermo Fisher Scientific, Inc.
10.5 Laboratory Corporation of America Holdings
10.6 Quest Diagnostics Incorporated
10.7 Agilent Technologies, Inc.
10.8 Sakura Finetechnical Co., Ltd.
10.9 Biogenex Laboratories
10.10 Bio SB
10.11 Neogenomics Laboratories, Inc.

  • Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Knowledge Store
11.4 Introducing Rt: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports
11.7 Author Details

List of Tables:
Table 1 Healthcare Spending (% of GDP), By Country, 2005 vs. 2014
Table 2 Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 3 Global Anatomic Pathology Product & Service Market Size, By Region, 2014-2021 (USD Million)
Table 4 Global Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 5 Global Anatomic Pathology Market Size for Tissue Processing Systems, By Region, 2014-2021 (USD Million)
Table 6 Global Anatomic Pathology Market Size for Slide Staining Systems, By Region, 2014-2021 (USD Million)
Table 7 Global Anatomic Pathology Market Size for Microtomes, By Region, 2014-2021 (USD Million)
Table 8 Global Other Anatomic Pathology Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 9 Global Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 10 Global Anatomic Pathology Reagents & Antibodies Market Size, By Region, 2014-2021 (USD Million)
Table 11 Global Anatomic Pathology Kits Market Size, By Region, 2014-2021 (USD Million)
Table 12 Global Anatomic Pathology Probes Market Size, By Region, 2014-2021 (USD Million)
Table 13 Global Other Anatomic Pathology Consumables Market Size, By Region, 2014-2021 (USD Million)
Table 14 Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 15 Global Anatomic Pathology Services Market Size, By Region, 2014-2021 (USD Million)
Table 16 Global Cytopathology Services Market Size, By Region, 2014-2021 (USD Million)
Table 17 Global Histopathology Services Market Size, By Region, 2014-2021 (USD Million)
Table 18 Global Other Anatomic Pathology Services Market Size, By Region, 2014-2021 (USD Million)
Table 19 Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 20 Anatomic Pathology Market Size for Disease Diagnosis, By Region, 2014-2021 (USD Million)
Table 21 Anatomic Pathology Market Size for Drug Discovery & Development, By Region, 2014-2021 (USD Million)
Table 22 Anatomic Pathology Market Size for Other Applications Market Size, By Region, 2014-2021 (USD Million)
Table 23 Global Anatomic Pathology Market Size, By Region, 2014-2021 (USD Million)
Table 24 North America: Anatomic Pathology Market Size, By Country, 2014-2021 (USD Million)
Table 25 North America: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 26 North America: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 27 North America: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 28 North America: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 29 North America: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 30 U.S.: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 31 U.S.: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 32 U.S.: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 33 U.S.: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 34 U.S.: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 35 Canada: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 36 Canada: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 37 Canada: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 38 Canada: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 39 Canada: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 40 Europe: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 41 Europe: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 42 Europe: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 43 Europe: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 44 Europe: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 45 Asia: Anatomic Pathology Market Size, By Country, 2014-2021 (USD Million)
Table 46 Asia: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 47 Asia: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 48 Asia: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 49 Asia: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 50 Asia: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 51 Japan: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 52 Japan: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 53 Japan: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 54 Japan: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 55 Japan: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 56 China: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 57 China: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 58 China: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 59 China: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 60 China: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 61 India: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 62 India: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 63 India: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 64 India: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 65 India: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 66 RoA: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 67 RoA: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 68 RoA: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 69 RoA: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 70 RoA: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 71 RoW: Anatomic Pathology Market Size, By Product & Service, 2014-2021 (USD Million)
Table 72 RoW: Anatomic Pathology Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 73 RoW: Anatomic Pathology Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 74 RoW: Anatomic Pathology Services Market Size, By Type, 2014-2021 (USD Million)
Table 75 RoW: Anatomic Pathology Market Size, By Application, 2014-2021 (USD Million)
Table 76 Market Developments, 2014-2017
Table 77 Product Launches & Regulatory Approvals, 2014-2017
Table 78 Acquisitions, 2014-2017
Table 79 Agreements, Partnerships, and Collaborations, 2014-2017
Table 80 Expansions, 2014-2017

List of Figures:
Figure 1 Global Anatomic Pathology Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation and Region
Figure 4 Anatomic Pathology Market: Bottom-Up Approach
Figure 5 Anatomic Pathology Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Anatomic Pathology Market Size, By Product & Service, 2016 vs. 2021
Figure 8 Global Anatomic Pathology Instruments Market Size, By Type, 2016 vs. 2021
Figure 9 Global Anatomic Pathology Consumables Market Size, By Type, 2016 vs. 2021
Figure 10 Global Anatomic Pathology Services Market Size, By Type, 2016 vs. 2021
Figure 11 Global Anatomic Pathology Market Size, By Application, 2016 vs. 2021
Figure 12 Global Anatomic Pathology Market Size, By Region 2016 vs. 2021
Figure 13 Increasing Incidence of Cancer and Other Chronic Diseases Will Drive Growth in the Global Anatomic Pathology Market During the Forecast Period
Figure 14 the Services Segment Dominated the Anatomic Pathology Market in 2016
Figure 15 the Disease Diagnosis Application Segment Is Expected To Register the Highest CAGR from 2016 To 2021
Figure 16 Asia To Register the Highest CAGR During the Forecast Period
Figure 17 Anatomic Pathology Market: Drivers, Restraints, Opportunities, Challenges, and Trends
Figure 18 Global Incidence of Cancer, By Type (2012-2035)
Figure 19 Diseases Diagnosis Will Continue To Dominate the Anatomic Pathology Market During the Forecast Period
Figure 20 Anatomic Pathology Market: Geographic Snapshot (2016-2021)
Figure 21 North America: Anatomic Pathology Market Snapshot (2016-2021)
Figure 22 Asia: Anatomic Pathology Market Snapshot (2016-2021)
Figure 23 Product Launches Is the Key Strategy Adopted By Players Between 2013 & 2016
Figure 24 Global Anatomic Pathology Products Market Share Analysis, By Key Players, 2015
Figure 25 Geographic Revenue Mix of the Top 6 Players in the Anatomic Pathology Market
Figure 26 F. Hoffmann-La Roche Ag.: Company Snapshot (2015)
Figure 27 Danaher Corporation: Company Snapshot (2015)
Figure 28 Thermo Fisher Scientific, Inc.: Company Snapshot (2015)
Figure 29 Laboratory Corporation of America Holdings: Company Snapshot (2015)
Figure 30 Quest Diagnostics Incorporated: Company Snapshot (2015)
Figure 31 Agilent Technologies, Inc.: Company Snapshot (2015)
Figure 32 Neogenomics Laboratories, Inc.: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bio SB
  • Biogenex Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG.
  • MORE

The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

The anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1%.

On the basis of product and service, the market is segmented into instruments, consumables, and services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and others applications. In 2016, the disease diagnosis segment accounted for the largest share of the market. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.

Based on region, the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China, India, and Japan; the large population and rising prevalence of chronic diseases in these countries; improving standards of living; growing demand for quality medical care; increasing healthcare spending and government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for diagnostics are some major factors driving the high growth of this regional segment.

Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.)

Note: Product cover images may vary from those shown
5 of 5
  • Agilent Technologies, Inc.
  • Bio SB
  • Biogenex Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG.
  • Laboratory Corporation of America Holdings
  • Neogenomics Laboratories, Inc.
  • Quest Diagnostics Incorporated
  • Sakura Finetechnical Co., Ltd.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll